High frequency of t(12;21) in childhood acute lymphoblastic leukemia detected by RT-PCR

Pathology

Volumn 30, Issue 4, 1998, Pages 381-385

  Amor, David J ^a   Algar, Elizabeth M ^a   Slater, Howard R ^a   Smith, Peter J ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AML1; Childhood ALL; ETV6; TEL; Translocations

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 12; CHROMOSOME 12P; CHROMOSOME 13; CHROMOSOME 21; CHROMOSOME 21Q; CHROMOSOME 22; CONTROLLED STUDY; GENE FUSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031791987     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169666     Document Type: Article

References (19)

1. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 1997; 15: 1150-7.
2. Morgan GJ, Shiach C, Potter M. The clinical value of detecting gene rearrangements in acute leukemias. Br J Haematol 1994; 88: 459-64.
3. Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group Study. J Clin Oncol 1992; 10: 606-13.
4. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, et al. TEL/AML fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985-9.
5. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263-9.
6. Romana SP, Le Coniat M, Berger R. A new recurrent translocation in acute lymphoblastic leukemia. Genes, Chromosomes Cancer 1994; 9: 186-91.
7. Cayuela J, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel M, et al. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 1996; 88: 302-8.
8. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, et al. TEL/AML1 dimerizes and is associated with a favourable outcome in childhood acute lymphoblastic leukemia. Bood 1996; 88: 4252-8.
9. Lanza C, Volpe G, Basso G, Gottardi E, Barisone E, Spinelli M, et al. Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukemia. Br J Haematol 1997; 97: 460-2.
10. Liang D, Chou T, Chen J, et al. High incidence of TEL/AML 1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 991-3.
11. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R. et al. The t(12;21) of acute lymphoblaslic leukemia results in a TEL-AML1 gene fusion. Blood 1995; 85: 3662-70.
12. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P. et al. Fusion of the TEL gene on 12p13 to the AML 1 gene on 21q22 in acute lymphoblastic leukemia. Proc Nat Acad Sci USA 1995; 92: 4917-21.
13. Kim D, Moldwin RL, Vignon C, Bohlander SK, Yoshimasa S, Giordano L. et al. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 1996; 88: 785-94.
14. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ. et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group Study, Blood 1991; 76: 117-22.
15. Privitera E, Rivolta A, Ronchetti D, Mosna G, Giudici G, Biondi A. Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukemia. J. Haematol 1996; 92: 653-8.
16. Golub TR, Barker GF, Stegmaier K, Gilliland DG. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms. Curr Top Microbiol Immunol 1996; 211: 279-89.
17. Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP. et al. Mutational analysis of the candidate tumor suppressor genes TEL and KIP 1 in childhood acute lymphoblastic leukemia. Cancer Res 1996; 56: 1413-7.
18. Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard OA, Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167-70.
19. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM et al. Case-control study suggests a favourable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite based therapy: a Pediatric Oncology Group Study. Blood 1997; 89: 1143-6.